NANOGHOSTS
NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
NANOGHOSTS
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Total Employee:
1+
Status:
Active
Total Funding:
5 M USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Healthwire
Healthwire is a health-tech startup.
IVF Access
IVF Access is a healthcare startup.
Janpix
Janpix operates as an oncology-focused startup.
Protai
Protai is an AI-powered drug discovery startup.
Current Employees Featured
Yonatan Malca Chief Executive Officer @ NanoGhosts
Chief Executive Officer
2019-11-01
Marcelle Machluf Co-Founder and inventor @ NanoGhosts
Co-Founder and inventor
Founder
Investors List
aMoon Fund
aMoon Fund investment in Venture Round - NanoGhosts
More informations about "NanoGhosts"
Targeted Drug Delivery Platform | Company - NanoGhost
NanoGhosts can be loaded with various drug types (i.e. small molecules, DNA, RNA, peptides, proteins), preserve MSC’s tropism to cancer cells, and selectively penetrate tumors (as demonstrated in various preclinical models of solid …See details»
NanoGhosts - Crunchbase Company Profile & Funding
Organization. NanoGhosts . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. NanoGhosts is a cancer drug startup. Tel Aviv, …See details»
NanoGhost - LinkedIn
NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known ...See details»
NanoGhost 2025 Company Profile: Valuation, Funding …
NanoGhost General Information Description. Developer of a drug-delivery technology designed to shrink the deadliest forms of cancer by precisely …See details»
NanoGhost - aMoon
NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors, leading to a major reduction in tumor size and prolonged survival.See details»
NanoGhost - Israeli Startup | Startup Nation Finder
May 20, 2020 Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase …See details»
NanoGhost - Products, Competitors, Financials, Employees, …
Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company NanoGhosts turns stem cells into a drug delivery system that specifically targets cancerous tumors Hagar …See details»
NanoGhosts for a targeted fight against cancer - Haaretz
Jan 14, 2025 Targeted Cancer Treatments Are Currently Considered the Hottest Field in the Biotech World. NanoGhost, an Israeli Biotech Company, Brings One of the Most Innovative …See details»
Nano-Ghosts: A naturally targeted drug and gene delivery system
Nanoghosts derived from mesenchymal stem cells and retaining their unique surface-associated tumor-targeting capabilities were redesigned as a selective and safe universal nonviral gene …See details»
NanoGhost | Targeted Drug Delivery Platform | Home
NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites …See details»
Targeted Drug Delivery Platform | Technology
NGs are nanovesicles derived from the cell membranes of allogeneic Mesenchymal Stem Cells (MSCs). Using the NanoGhost technology, MSCs are emptied from their intracellular content and the cell membrane is downsized to …See details»
Nanoghosts: Mesenchymal Stem cells derived ... - ScienceDirect
Sep 10, 2021 In previous research, we reported the potential of a new biomimetic tumor-targeted platform, called nanoghosts (NGs), which can work as vehicles for drug-delivery. NGs …See details»
NanoGhosts for a Targeted Fight Against Cancer - Technion
Published By: Editors at Haaretz Publish Date: January 14, 2025 Targeted cancer treatments are currently considered the hottest field in the biotech world. NanoGhost, an Israeli biotech …See details»
NanoGhost - VentureRadar
"NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), …See details»
NanoGhosts - Contacts, Employees, Board Members, Advisors
NanoGhosts is a cancer drug startup. Start Free Trial . Chrome ExtensionSee details»
Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for …
Aug 31, 2023 These cargoes are so called “nanoghosts.” This review article summarizes the current applications of nanoghosts, the promising potential of MSCs to be applied in …See details»
Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting …
Jun 20, 2013 The ultimate goal in cancer therapy is achieving selective targeting of cancer cells. We report a novel delivery platform, based on nanoghosts (NGs) produced from the …See details»
NanoGhosts - Funding, Financials, Valuation & Investors
Dec 24, 2020 How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Dec 24, 2019: Venture Round - …See details»
Nanoghosts: Mesenchymal Stem cells derived nanoparticles as a
Sep 10, 2021 Osteoarthritis (OA) is a chronic degenerative disease, which affects the joints and is characterized by inflammation, cartilage loss and bone changes. Nowadays, there are no …See details»
Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform …
Mar 9, 2016 Nanoghosts derived from mesenchymal stem cells and retaining their unique surface-associated tumor-targeting capabilities were redesigned as a selective and safe …See details»